Single-use systems for biotechnology products
By Scott Rudge, COO, RMC Pharmaceutical Solutions Inc
Articles
Filter by
Improving healthcare professional engagement: Why quality customer data is key
By Guillaume Roussel, Director of Strategy, Veeva OpenData, Europe, Veeva Systems
Alliance management organisational development: A Bayer perspective
By Christoph Huwe, Strategic Alliance Manager Therapeutics at Bayer Pharmaceuticals, Global External Innovation & Alliances
2017 pipelines: Analysing future trends in the $12billion diabetes market
By Dr David Pugh, IDTechEx
Serialisation reconciliation: a blind spot in your finished product’s manufacturing compliance?
By Pasi Kemppainen, Executive Consultant, Pharma Serialisation and Traceability
How Panacea is paving the way for vaccine immunotherapies
By Niamh Marriott, Junior Editor
Redefining Pharma’s relationship with healthcare
By Robert Groebel, Vice President of global medical strategy, Veeva
Seal of approval: What makes a seal safe, hygienic and cost-effective?
By Russ Pimblett, Business Development Manager (Food, Pharmaceutical and Biomedical), FTL
Lipid-based formulations: Their advantages in early development
By Kaspar van den Dries PhD, Senior Director and Principal Scientist, Solid Dose Development, Patheon
Gilead on HIV: New research, new treatments and the potential for a cure
By Mike Elliott, Vice President, Medical Affairs, Gilead Sciences
Squeezing ROI from your serialisation initiative
By Mark Davison, CEO, Blue Sphere Health Ltd
Live stream from Pittcon 2017
By Niamh Marriott, Junior Editor
Fertile ground: Why Merck is investing in fertility treatment centres
By Dorothea Wenzel, Senior VP Global Business Franchise Fertility, Merck
UPDATE: The Cancer Drugs Fund
By Niamh Louise Marriott, Digital Editor
Follow: